Molbio Diagnostics IPO opens today: GMP at 15% — Check price band. Should you subscribe?
· economictimes.indiatimes.com
Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics valuations are broadly in line with industry benchmarks. The company is also being offered at a discount to the average P/E multiple of 64.9x for its listed peers, according to analysts.
Live Events
How Molbio Diagnostics Plans to Use IPO Funds
About Molbio Diagnostics
Strong Financial Performance
Should You Subscribe?
as a Reliable and T...